PGNY EBITDA | Progyny, Inc.

Progyny, Inc. (PGNY) EBITDA

2026-06-30: Basis Reported; EBITDA $41.63M*; Operating income $40.00M; Depreciation and amortization $1.62M*.
2026-03-31: Basis Reported; EBITDA $36.86M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $16.59M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $22.80M*; Operating income $21.53M; Depreciation and amortization $1.27M*.

Complete source-backed ebitda history.

Available history: 2017-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$41.63M*	$40.00M	$1.62M*	$350.51M	11.88%*	$6.22M*	$50.42M*	$261.21M	$3.30M	(m)	$13.09M
2026-03-31	Reported	$36.86M	(m)	(m)	(m)	11.22%	$6.35M	$45.95M	$245.43M	$2.80M	(m)	$12.65M
2025-12-31	Reported	$16.59M	(m)	(m)	(m)	5.21%	(m)	(m)	$241.52M	(m)	(m)	$5.37M
2025-09-30	Reported	$22.80M*	$21.53M	$1.27M*	$313.35M	7.27%*	$4.68M*	$50.67M*	$240.51M	$2.60M	(m)	$10.10M
2025-06-30	Reported	$25.56M*	$24.36M	$1.21M*	$332.87M	7.68%*	$5.27M*	$55.51M*	$253.90M	$2.30M	(m)	$9.96M
2025-03-31	Reported	$25.28M	(m)	(m)	(m)	7.80%	$2.84M	$49.81M	$248.24M	$1.50M	(m)	$11.48M
2024-12-31	Reported	$16.66M	(m)	(m)	(m)	5.58%	(m)	(m)	$235.00M	(m)	(m)	$7.13M
2024-09-30	Reported	$13.29M*	$12.46M	$837.00K*	$286.63M	4.64%*	$1.79M*	$44.52M*	$227.38M	(m)	(m)	$7.54M
2024-06-30	Reported	$21.44M*	$20.69M	$754.00K*	$304.09M	7.05%*	$866.00K*	$56.69M*	$235.81M	(m)	(m)	$8.58M
2024-03-31	Reported	$19.24M	(m)	(m)	(m)	6.92%	$850.00K	$25.73M	$215.67M	(m)	(m)	$5.62M
2023-12-31	Reported	$14.43M	(m)	(m)	(m)	5.35%	(m)	(m)	$213.05M	(m)	(m)	$2.79M
2023-09-30	Reported	$18.77M*	$18.19M	$579.00K*	$280.89M	6.68%*	$953.00K*	$54.18M*	$218.27M	(m)	(m)	$5.03M
2023-06-30	Reported	$15.71M*	$15.18M	$527.00K*	$279.37M	5.62%*	$759.00K*	$76.01M*	$218.73M	(m)	(m)	$2.18M
2023-03-31	Reported	$15.55M	(m)	(m)	(m)	6.02%	$1.25M	$20.96M	$199.75M	(m)	(m)	-$1.35M
2022-12-31	Reported	$3.75M	(m)	(m)	(m)	1.75%	(m)	(m)	$169.83M	(m)	(m)	$733.00K
2022-09-30	Reported	$11.66M*	$11.26M	$405.00K*	$205.37M	5.68%*	$1.24M*	$20.89M*	$159.38M	(m)	(m)	-$1.67M
2022-06-30	Reported	$9.22M*	$8.84M	$386.00K*	$195.00M	4.73%*	$490.00K*	$19.25M*	$151.12M	(m)	(m)	$135.00K
2022-03-31	Reported	$306,000.00	(m)	(m)	(m)	0.18%	$790.00K	-$11.26M	$139.27M	(m)	(m)	-$5.11M
2021-12-31	Reported	$128,000.00	(m)	(m)	(m)	0.10%	(m)	(m)	$102.44M	(m)	(m)	-$15.48M
2021-09-30	Reported	$9.33M*	$9.06M	$267.00K*	$122.28M	7.63%*	$718.00K*	$24.16M*	$93.79M	(m)	(m)	-$7.68M
2021-06-30	Reported	$11.95M*	$11.66M	$296.00K*	$128.65M	9.29%*	$430.00K*	-$7.47M*	$99.03M	(m)	(m)	-$6.81M
2021-03-31	Reported	$12.23M	(m)	(m)	(m)	10.01%	$369.00K	$532.00K	$93.23M	(m)	(m)	-$3.37M
2020-12-31	Reported	$1.63M	(m)	(m)	(m)	1.62%	(m)	(m)	$79.64M	(m)	(m)	-$37.90M
2020-09-30	Reported	$5.29M*	$4.83M	$462.00K*	(m)	(m)	$149.00K*	$15.33M*	$78.09M	(m)	(m)	$0.00*
2020-06-30	Reported	-$612.00K*	-$1.07M	$460.00K*	(m)	(m)	$98.00K*	$2.20M*	$52.65M	(m)	(m)	$0.00*
2020-03-31	Reported	$3.95M	(m)	(m)	(m)	4.88%	$693.00K	$12.14M	$64.42M	(m)	(m)	$116.00K
2019-12-31	Reported	$1.68M	(m)	(m)	(m)	2.58%	(m)	(m)	$53.35M	(m)	(m)	-$77.00K
2019-09-30	Reported	$3.60M*	$3.07M	$535.00K*	(m)	(m)	$420.00K*	$5.88M*	$48.88M	(m)	(m)	$25.00K
2019-06-30	Reported	$2.90M*	$2.35M	$549.00K*	(m)	(m)	$133.00K*	$4.25M*	$44.72M	(m)	(m)	$64.00K
2019-03-31	Reported	$3.62M	(m)	(m)	(m)	7.67%	$125.00K	-$6.17M	$37.23M	(m)	(m)	$0.00
2018-12-31	Reported	-$215,000.00	(m)	(m)	(m)	-0.74%	(m)	(m)	$23.77M	(m)	(m)	-$547.00K
2018-09-30	Reported	(m)	-$587.00K	(m)	(m)	(m)	(m)	(m)	$22.75M	(m)	(m)	-$395.00K
2018-06-30	Reported	(m)	-$317.00K	(m)	(m)	(m)	(m)	(m)	$21.12M	(m)	(m)	-$289.00K
2018-03-31	Reported	(m)	-$1.84M	(m)	(m)	(m)	(m)	(m)	$18.32M	(m)	(m)	-$546.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Rolling	(m)	$112.13M*	(m)	$1.31B*	(m)	(m)	(m)	$988.68M*	(m)	(m)	$41.20M*
2026-03-31	Rolling	(m)	$96.49M*	(m)	$1.29B*	(m)	(m)	(m)	$981.37M*	(m)	(m)	$38.09M*
2025-12-31	Reported	$90.23M	(m)	(m)	(m)	7.00%	$18.41M	$210.19M	$984.18M	$9.50M	(m)	$36.91M
2025-12-31	Rolling	(m)	$85.28M*	(m)	$1.29B*	(m)	(m)	(m)	$984.18M*	(m)	(m)	$36.91M*
2025-09-30	Rolling	(m)	$85.84M*	(m)	$1.27B*	(m)	(m)	(m)	$977.65M*	(m)	(m)	$38.67M*
2025-06-30	Rolling	(m)	$76.77M*	(m)	$1.24B*	(m)	(m)	(m)	$964.52M*	(m)	(m)	$36.11M*
2025-03-31	Rolling	(m)	$73.10M*	(m)	$1.21B*	(m)	(m)	(m)	$946.43M*	(m)	(m)	$34.73M*
2024-12-31	Reported	$70.63M	(m)	(m)	(m)	6.05%	$5.41M	$179.10M	$913.86M	(m)	(m)	$28.87M
2024-12-31	Rolling	(m)	$67.45M*	(m)	$1.17B*	(m)	(m)	(m)	$913.86M*	(m)	(m)	$28.87M*
2024-09-30	Rolling	(m)	$65.47M*	(m)	$1.14B*	(m)	(m)	(m)	$891.90M*	(m)	(m)	$24.53M*
2024-06-30	Rolling	(m)	$71.20M*	(m)	$1.13B*	(m)	(m)	(m)	$882.79M*	(m)	(m)	$22.02M*
2024-03-31	Rolling	(m)	$65.70M*	(m)	$1.11B*	(m)	(m)	(m)	$865.72M*	(m)	(m)	$15.62M*
2023-12-31	Reported	$64.47M	(m)	(m)	(m)	5.92%	$3.64M	$188.81M	$849.80M	(m)	(m)	$8.65M
2023-12-31	Rolling	(m)	$62.18M*	(m)	$1.09B*	(m)	(m)	(m)	$849.80M*	(m)	(m)	$8.65M*
2023-09-30	Rolling	(m)	$51.69M*	(m)	$1.03B*	(m)	(m)	(m)	$806.58M*	(m)	(m)	$6.59M*
2023-06-30	Rolling	(m)	$44.76M*	(m)	$957.46M*	(m)	(m)	(m)	$747.69M*	(m)	(m)	-$110.00K*
2023-03-31	Rolling	(m)	$38.41M*	(m)	$873.09M*	(m)	(m)	(m)	$680.07M*	(m)	(m)	-$2.15M*
2022-12-31	Reported	$24.94M	(m)	(m)	(m)	3.17%	$3.24M	$80.39M	$619.59M	(m)	(m)	-$5.92M
2022-12-31	Rolling	(m)	$23.34M*	(m)	$786.91M*	(m)	(m)	(m)	$619.59M*	(m)	(m)	-$5.92M*
2022-09-30	Rolling	(m)	$19.85M*	(m)	$700.14M*	(m)	(m)	(m)	$552.20M*	(m)	(m)	-$22.13M*
2022-06-30	Rolling	(m)	$17.66M*	(m)	$617.06M*	(m)	(m)	(m)	$486.62M*	(m)	(m)	-$28.14M*
2022-03-31	Rolling	(m)	$20.48M*	(m)	$550.71M*	(m)	(m)	(m)	$434.53M*	(m)	(m)	-$35.08M*
2021-12-31	Reported	$33.64M	(m)	(m)	(m)	6.72%	$2.13M	$26.04M	$388.49M	(m)	(m)	-$33.33M
2021-12-31	Rolling	(m)	$32.34M*	(m)	$500.62M*	(m)	(m)	(m)	$388.49M*	(m)	(m)	-$33.33M*
2021-09-30	Rolling	(m)	$33.69M*	(m)	(m)	(m)	(m)	(m)	$365.68M*	(m)	(m)	-$55.75M*
2021-06-30	Rolling	(m)	$29.45M*	(m)	(m)	(m)	(m)	(m)	$349.98M*	(m)	(m)	-$48.07M*
2021-03-31	Rolling	(m)	$16.72M*	(m)	(m)	(m)	(m)	(m)	$303.60M*	(m)	(m)	-$41.27M*
2020-12-31	Reported	$10.25M	(m)	(m)	(m)	2.97%	$1.04M	$36.20M	$274.80M	(m)	(m)	-$37.78M
2020-12-31	Rolling	(m)	$8.35M*	(m)	(m)	(m)	(m)	(m)	$274.80M*	(m)	(m)	-$37.78M*
2020-09-30	Rolling	(m)	$8.33M*	(m)	(m)	(m)	(m)	(m)	$248.52M*	(m)	(m)	$39.00K*
2020-06-30	Rolling	(m)	$6.57M*	(m)	(m)	(m)	(m)	(m)	$219.30M*	(m)	(m)	$64.00K*
2020-03-31	Rolling	(m)	$10.00M*	(m)	(m)	(m)	(m)	(m)	$211.37M*	(m)	(m)	$128.00K*
2019-12-31	Reported	$11.81M	(m)	(m)	(m)	5.14%	$2.96M	-$1.53M	$184.18M	(m)	(m)	$12.00K
2019-12-31	Rolling	(m)	$9.68M*	(m)	(m)	(m)	(m)	(m)	$184.18M*	(m)	(m)	$12.00K*
2019-09-30	Rolling	(m)	$7.83M*	(m)	(m)	(m)	(m)	(m)	$154.60M*	(m)	(m)	-$458.00K*
2019-06-30	Rolling	(m)	$4.17M*	(m)	(m)	(m)	(m)	(m)	$128.47M*	(m)	(m)	-$878.00K*
2019-03-31	Rolling	(m)	$1.50M*	(m)	(m)	(m)	(m)	(m)	$104.88M*	(m)	(m)	-$1.23M*
2018-12-31	Reported	-$1.57M	(m)	(m)	(m)	-1.49%	$579.00K	$2.27M	$85.97M	(m)	(m)	-$1.78M
2018-12-31	Rolling	(m)	-$3.45M*	(m)	(m)	(m)	(m)	(m)	$85.97M*	(m)	(m)	-$1.78M*
2017-12-31	Reported	-$9.45M	(m)	(m)	(m)	-19.44%	$612.00K	-$9.47M	$41.18M	(m)	(m)	-$3.00K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
agilon health, inc. (AGL)	United States	$1.272B	-7.76
VIEMED HEALTHCARE, INC. (VMD)	United States	$0.336B	29.92
Park Dental Partners, Inc. (PARK)	United States	$0.094B
BioRestorative Therapies, Inc. (BRTX)	United States	$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)	United States	$0.033B	-11.02
MANGOCEUTICALS, INC. (MGRX)	United States	$0.010B	-0.43
Sotera Health Co (SHC)	United States	$5.271B	30.96
DAVITA INC. (DVA)	United States	$11.147B	16.80